From left to right: Philippe Delaporte, vice-president of research at AMU, Aurélie Philippe, CNRS regional delegate, Fabrice Roche-Marin, Inserm DR2 PACAC heritage manager, Didier Samuel, Inserm CEO, Dominique Nobile, Inserm PACAC regional delegate, Alain Eychène, Inserm ITMO Cancer director
On 24 March, as part of the celebrations for the 50th anniversary of the Marseille Cancer Research (CRCM), the Institut Paoli-Calmettes hosted the institutional day which brought together the the CRCM’s supervisory bodies: Inserm, CNRS, Aix-Marseille University and Institut Paoli-Calmettes.
The management of the institutions were represented by Prof. Didier Samuel, CEO of Inserm, Prof. Eric Berton, President of Aix-Marseille University, Mrs. Aurélie Philippe, Regional Delegate of CNRS and Prof. Norbert Vey, Director General of the IPC took turns to speak to celebrate the history and successes of the CRCM over the years. Prof. Jean-Paul Borg, Director of the CRCM, then opened the very rich scientific programme with a retrospective of the CRCM’s medical-scientific discoveries, which is unique and draws its strength from the mix between its researchers, doctors, pharmacists and engineers. The heads of the CRCM’s departments then took turns to present the activities of their departments and their constituent teams: Prof. Raynier Devillier and Dr. Estelle Duprez for the Onco-Hematology and Immunology Department Haematology and Immuno-Oncology Department; Dr. Pierre-Henri Gaillard and Dr. Bertrand Llorente, for the Genome Integrity Department; and Dr Sophie Vasseur for the ‘Cellular Communication and Microenvironment’ Department Microenvironment’ and Prof. Joseph Ciccolini and Dr. Nelson Dusetti for the ‘Translational Research and Research and Innovative Therapies’.
To close the conference, Dr Juan Iovanna presented the “Pancreatic Cancer” programme, prefiguring the visit of the Fightcancer building (supported by Inserm) which will open in 2024 on the IPC site.
